Nplate (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia

5 years ago

by David Miller

952 Views

Written by David Miller

THOUSAND OAKS, Calif., Oct. 18, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!